Epidemiological and genetic characteristics of clinical carbapenemase-producing Enterobacterales isolates from Batna hospitals in Algeria Authors: Amel Benbouza, Ahmed Kassah-Laouar, Widad Chelaghma, Fayza Bouziane, Yassina Mebarki, Jean-Marc Rolain, Lotfi Loucif Published: 2024 ABSTRACT BackgroundCarbapenemase-producing Enterobacterales isolates are associated with significant mortality and have emerged as a major problem in healthcare settings worldwide.ObjectiveOur aim was to investigate the epidemiological and genotypic characteristics of carbapenemase-positive Enterobacterales isolates from patients hospitalised in three hospitals in the city of Batna, Algeria.MethodsBetween 2016 and 2019, a total of 5,316 clinical isolates were obtained. The collected isolates were identified using the VITEK-2 system. Demographic and microbiological data were collected as well as the antimicrobial susceptibility testing, phenotypic and molecular characterisation of carbapenemase and mcr-1 genes were performed.ResultsOut of the 5,316 isolates, 201 were carbapenem-resistant Enterobacterales isolates and 179 of them (89.05%) were positive for the production of carbapenemase, of which Klebsiella pneumoniae, Escherichia coli and Enterobacter cloacae were the most common. The blaOXA−48−like gene alone was detected in 147 isolates (82.12%) moreover, the blaNDM gene was detected in ten isolates (5.59%). Dual and triple combinations of carbapenemase genes were also observed here for the first time in Algeria: blaVIM and blaOXA−48−like; blaKPC, blaVIM and blaOXA−48−like; blaVIM and blaNDM; blaKPC, blaNDM and blaVIM; blaNDM and blaOXA−48−like genes. In addition, resistance to both colistin and carbapenem antibiotics was detected in eight isolates, however none of them was positive for the mcr-1 gene.ConclusionThis is the first study reporting the detection of carbapenemase genes in Klebsiella aerogenes, Enterobacter sakazakii, Raoultella ornithinolytica, Serratia ficaria, and Serratia marcescens and specific carbapenemase gene combinations in Algeria. The present study revealed that blaOXA−48−like were found to be the predominant carbapenemase genes in Batna hospitals. Background Due to their broad spectrum of activity and their excellent resistance to hydrolysis by the majority of the β-lactamase enzymes, carbapenems are considered as one of the last therapeutic lines against some nosocomial or hospital-acquired infections caused by multidrug-resistant Gram-negative pathogens [1, 2]. Unfortunately, this β-lactam class is currently threatened by the dissemination of resistant bacteria especially Enterobacterales species worldwide [3, 4]. Carbapenemase-positive Enterobacterales isolates have become highly prevalent in various geographic areas, including the Middle East and the Mediterranean countries [3, 5]. The rate of carbapenemases producing isolates has increased significantly, and this is mostly attributed to the horizontal transfer of carbapenemase determinants [4]. Resistance to carbapenems results from a multitude of mechanisms, including the overproduction of AmpC β-lactamase or the production of extented-spectrum β-lactamases associated with reduced outer membrane permeability or efflux. Additionally, carbapenemase production was identified as the main mechanism in Enterobacterales species [4]. Acquiring of such enzymes is particularly challenging due to their ability to hydrolyse almost all β-lactam antibiotics, including carbapenems, leading to a point where no β-lactams retain their effectiveness [6]. Globally, the common carbapenemases detected in Enterobacterales isolates were: the Ambler class A (mostly KPC-type), metallo-β-lactamases (MBLs) (such as NDM, and VIM types) and oxacillinases (OXA-48-like) which are the most common type. These include OXA-48, which was abundantly reported in Enterobacterales isolates, in particular from North African countries [7]. Enterobacterales species are among the most common nosocomial pathogens, they cause a wide variety of infections ranging from self-limiting to life-threatening infections [3]. The ever increasing rate of infections due to carbapenemase-producing Enterobacterales (CPE) isolates is one of the most worrying concerns to health services around the world, since the therapeutic options for these infections are generally very limited, or even lacking [3, 8]. These species with such carbapenem resistance mechanisms are more virulent and are associated with higher levels of antimicrobial resistance, with more rapid diffusion, and worse outcomes. In contrast, non-carbapenemase-producing Enterobacterales isolates have been associated with asymptomatic carriage and without person-to-person transmission [9, 10]. In Algeria, the situation regarding CPE isolates has worsened in recent years. Since their detection in 2008 [11], different carbapenemase genes have been reported, including the blaKPC, blaVIM, blaNDM and blaOXA−48−like genes, where the OXA-48 enzyme represents the most common carbapenemase type circulating and reported in Algeria among Enterobacterales isolates [11–13]. Since their first report, the OXA-48-like producing Enterobacterales has emerged in an endemic way and as significant pathogen due to clonal, nonclonal, intra-hospital and interregional dissemination [7]. Current treatment options for infections caused by such bacteria are extremely scarce and are limited to last-line antibiotics such as colistin and more recently to the two novel β-lactam-β-lactamase inhibitor combinations, meropenem-vaborbactam and ceftazidime-avibactam [8]. However, the clinical potential of colistin has been considerably compromised by the global dissemination of the plasmid-borne colistin resistance gene “mcr” which is more challeging in carbapenem-resistant isolates [14, 15]. In this era of globalisation, bacteria with such high levels of resistance have spread rapidly around the world, making it extremely important to identify the types and frequency of carbapenemase genes circulating in our country. The aim of this study was to inverstigate the epidemiological and genotypic characteristics of carbapenemase-positive Enterobacterales isolates from hospitalised patients in three different hospital establishments in the city of Batna, Algeria. Materials and methods Study population and area This prospective study was conducted over a period of four years between January 2016 to December 2019 in three hospital establishments ranging in size from 140 to 650 beds in the city of Batna, Algeria. These three hospitals were Batna University Hospital (CHU) (Benflis Touhami, 650 beds), the Public Hospital Establishment (EPH) (Haouas Salah, 140 beds), and the Cancer Centre (CAC) (Hamdiken Belkacem, 240 beds). Bacterial strains Over the study period, a total of 5,316 Enterobacterales isolates were collected from Batna university hospital (n = 3346), the cancer centre (n = 1020) and the public hospital establishment (n = 950). These isolates were obtained from different clinical specimens including: pus, blood, urine, abscess, tracheal aspirate, bronchopulmonary secretions, wounds, ears, nose, throat, rectal swab, cerebrospinal fluid, spit, prosthetic material and ascites sent to microbiology laboratory. Clinical samples were analysed using standard laboratory techniques. Two-hundred-one (n = 201) out of them were ertapenem or imipenem non-susceptible Enterobacterales isolates and were consecutively collected from the aforementioned hospitals. Patient data were collected and included: demographic characteristics (age and gender), antibiotic therapy, previous hospitalisations in the last three months, clinical outcome data, clinical presentation, site of infection, and any other associated multidrug-resistant bacteria. Identification of the obtained isolates was carried out using the VITEK-II automated system (BioMérieux, France). Antimicrobial susceptibility testing Antibiotic susceptibility testing was performed using disc diffusion method and the antibiotic minimum inhibitory concentration determination using the VITEK AST-GN cards (BioMérieux, France). With the exception of piperacillin, temocillin, cefepime, meropenem and aztreonam drugs which were tested only by the disc diffusion method, the following antibiotics: ampicillin, ticarcillin, amoxicillin-clavulanic acid, piperacillin-tazobactam, cefalotin, cefoxitin, cefotaxime, ceftazidime, ceftriaxone, ertapenem, imipenem, amikacin, tobramycin, gentamicin, nalidixic acid, ciprofloxacin, ofloxacin, and trimethoprim-sulfamethoxazole were tested by both disc diffusion method and the Vitek system. The obtained carbapenem-resistant Enterobacterales (CRE) isolates were tested for their colistin susceptibility using a selective isolation. All presumptive CREs were subjected to selective enrichment step in brain heart infusion broth with 3 µg/ml of colistin and after an overnight incubation at 37 °C, 10 µl of the enrichment suspension were inoculated onto nutrient agar supplemented with the association vancomycin (64 µg/ml) and colistin (3 µg/ml) and incubated at 37 °C for 24 h [16]. Absence of growth or characteristic growth of negative and positive control strains on the different tested culture media was used for quality control purposes. The minimum inhibitory concentration (MIC) of colistin was carried out by broth microdilution methods according to the European Committee on Antimicrobial Susceptibility Testing guidelines (2019). E. coli ATCC 25922 strain was used for quality control. Antibiotic susceptibility testing results were interpreted according to the Antibiogram Committee of the French Society for Microbiology (CASFM). Phenotypic screening for carbapenemase production Phenotypic screening for carbapenemase production was performed by the modified carba NP test, modified Hodge test, and the EDTA combined disk test with imipenem as the antibiotic substrate on Mueller Hinton agar plates [17, 18]. Molecular detection of carbapenemase and mcr genes All phenotypically confirmed carbapenemase-producing isolates underwent molecular screening to detect resistant genes. Genotypic characterisation was performed by real time PCR to screen for the most common carbapenemase-encoding genes, blaKPC, blaVIM, blaIMP, blaNDM, and blaOXA−48−like and the mcr-1 gene which encodes colistin resistance. Genomic DNA extraction was carried out using the SaMag Bacterial DNA Extraction Kit (SM006) (Sacace Biotechnologies). Thereafter, the presence of carbapenemase genes in the selected isolates was performed with a SaCycler-96TM (Sacace) real-time PCR detection system. PCR mixtures were prepared in 35 µl total volume containing 7 µl of enzyme (taq polymerase), 7 µl of each DNA and 21 µl of pre-filled reagent in PCR tubes supplied by the manufacturer as part of the detection kits: MDR KPC/OXA Real-TM PCR (C2-100FRT, Sacace Biotechnologies Srl, Como, Italy), MDR MBL (VIM, IMP, NDM) Real TM (C1-100FRT, Sacace Biotechnologies Srl, Como, Italy) and Resistance Carbapenems-3 for blaOXA−48 gene (T01786-50-T, Sacace Biotechnologies Srl, Como, Italy). The detection of mcr-1 gene in the selected isolates was carried out using the following specific primers (F and R) and probe (P): F; GCAGCATACTTCTGTGTGGTAC, R; ACAAAGCCGAGATTGTCCGCG, P; 6 FAM-GACCGCGACCGCCAATCTTACC-TAMRA. Negative control (PCR mix) and positive control templates were included in each PCR. Statistical analysis The evaluation of the prevalence of carbapenemase-encoding-genes related to the three most common Enterobacterales species, as well as their source (hospital establishment and ward) was analysed by performing the Fisher’s exact test. The level of significance was set at a p-value < 0.05. Statistical analyses and graphical representations were performed using the RStudio interface (version 2023.3.0.386) (Posit team, 2023) of the R software (version 4.2.3) (R Core Team, 2023). Results Screening for carbapenemase production Between January 2016 and December 2019, 201 carbapenem-resistant Enterobacterales isolates were collected. Based on phenotypic characterisation results, 179 out of 201 strains were positive for the modified carba NP test (98.05%, 179/201), whereas 154 isolates (76.62%, 154/201) were positive for modified Hodge test. Moreover twenty-seven out of 179 isolates with carbapenemase activity (positive modified carba NP test isolates) were positive for the EDTA test (15.08%, 27/179). Bacterial species identification In this study, the obtained isolates with carbapenemase activity were identified as K. pneumoniae (n = 106; 59.22%), E. coli (n = 37; 20.67%), Enterobacter cloacae (n = 13; 7.26%), Raoultella terrigena (n = 9; 5.03%), Klebsiella aerogenes (n = 5; 2.79%), Enterobacter sakazakii (n = 3; 1.67%). In addition, one isolate was identified as each of Raoultella ornithinolytica (n = 1; 0.56%), Klebsiella oxytoca (n = 1; 0.56%), Citrobacter Koseri (n = 1; 0.56%), Serratia ficaria (n = 1; 0.56%), Serratia marcescens (n = 1; 0.56%), and Proteus mirabilis (n = 1; 0.56%). Clinical characteristics From this survey, a total of non-duplicated 179 Enterobacterales producing carbapenemases were obtained out of 5,316 clinical isolates collected from three hospitals included in the study (179/5,316; 3.37%). Most of the isolates were from patients hospitalised in Batna university hospital (156/3346; 4.66%), followed by cancer centre (17/1020; 1.67%), and the Batna public hospital establishment (6/650; 0.92%). These CPE isolates were obtained from patients with ages ranging from 6-months to 88 years old. Of the patients enrolled, males accounted for 52.51% (n = 94) of all cases. However, 47.49% were females (n = 85) and only 26.82% of patients (n = 48) had a history of hospitalisation within the previous days (Fig. 1). Fig. 1Sankey diagram showing the demographic characteristics of the study population Sankey diagram showing the demographic characteristics of the study population The obtained CPE strains were isolated from patients hospitalised in the burns ward (n = 72), followed by intensive care ward (n = 39), haematology (n = 30), neurosurgery (n = 11), surgery (n = 8), infectious diseases (n = 5), internal medicine (n = 5), nephrology (n = 3), paediatric oncology (n = 2), oncology (n = 1), otolaryngology (n = 1), orthopaedics (n = 1), and urology ward (n = 1). In this study, the hight prevalence of CPE acquisition was observed particularly, in four wards at Batna university hospital as follows: haematology (15.44%), burns (14.04%), intensive care ward (7.20%) and the neurosurgery ward (6.88%). From 179 CPE isolates, 100 (55.86%) were obtained from pus samples whereas the remaining isolates were collected from different clinical specimens, including blood cultures (n = 37; 20.67%), urine (n = 18; 10.05%), catheters (n = 8; 4.47%), rectal swabs (n = 5; 2.79%), cerebrospinal fluid samples (n = 5; 2.79%), tracheal aspirations (n = 1; 0.56%), intubation probes (n = 1; 0.56%), urinary catheters (n = 1; 0.56%), skin samples (n = 1; 0.56%), ascites fluid (n = 1; 0.56%), and prosthesis equipment (n = 1; 0.56%). Of these patients, 81 were identified as suffering from burns (45.25%), 24 had cancer (13.41%), 13 of patients had leukaemia (7.26%), 10 had a urinary tract infection (5.59%), 8 had pulmonary valve agenesis (4.47%), 5 of each had a stroke, coma, meningitis, acute respiratory distress, and spina bifida (2.79%), 3 had septicaemia (1.68%), 3 had a head trauma (1.68%), 2 had cirrhosis (1.12%), and one of each patient (0.56%) had a cholecystectomy, disembowelment, femoral neck fractures, anal fistula, haemothorax, chronic renal failure, abdominal mass, intestinal obstruction, pancreatitis, and laparotomy wound (Tables 1 and 2). Table 1Clinical and molecular characteristics of the obtained CPESpeciesHospitalGenderWardClinical specimensInfectionPrior hospitalisationETPIMPMEMCOLOutcomebla genesKlebsiella pneumoniae (n = 106)CAC: 11, PH:4, BUH: 91Female: 51Male: 55Burn: 50, Surgery: 5, Hematology: 11,Infectious disease: 4, Internal medicine: 1, Nephrology: 1, Neurosurgery: 4,Oncology: 1,pediatric Oncology: 1,Orthopaedics: 1,Intensive care: 26, Urology: 1Urine: 12, Rectal swab: 2,Blood:19, Catheter:5,Cerebrospinal fluid:1, Prosthesis equipment: 1, Skin sample: 1,Pus: 64, Urinary catheter: 1Stroke: 4,Pulmonary valves agenesis: 6,Burns: 55, Cancer: 12,Coma: 4,Acute respiratory distress: 3, Disembowelment: 1,Femoral neck fractures: 1, Hemothorax: 1, Urinary tract infection : 6,Leukaemia: 4, Abdominal mass: 1,Meningitis: 2, Pancreatitis: 1, Laparotomy wound: 1,Septicaemia: 1, Spina bifida: 2, Head trauma; 118.87% (n = 20)100%40.57%28.30%5.67%Death : 38.68%blaOXA−48: 94,blaNDM: 5,blaNDM +blaOXA−48: 3,blaVIM +blaOXA−48: 2, blaKPC +blaOXA−48 +blaVIM: 1,blaKPC +blaNDM +blaVIM: 1Escherichia coli (n = 37)BUH: 30,PH: 1, CAC: 6Male: 19Female: 18Burn: 6, Surgery: 2, Hematology: 16,Infectious disease: 1, Nephrology: 2,Neurosurgery: 4,Pediatric oncology: 1, Intensive care: 5Urine: 3, Rectal swab: 1,Blood: 15, Catheter: 1, LCR:3,pus: 13, Intubation probe: 1Stroke; 1,Burns: 7,Cancer: 8, Cholecystectomy: 1,Coma: 1,Respiratory distress:2,Urinary tract infection: 1,Chronic renal failure: 1,Leukaemia: 9, Meningitis: 2, Intestinal obstruction: 1, Septicaemia: 1, Spina bifida: 1, Head trauma: 162.16% (n = 23)100%45.95%27.03%0%Death: 35.14%blaOXA−48: 22, blaNDM: 4, blaVIM: 1 blaOXA−48 +blaNDM: 3 blaOXA−48 +blaVIM:3 blaNDM +blaVIM: 1 bla NDM + bla VIM + blaOXA−48: 2 bla KPC + bla VIM blaOXA−48: 1Enterobacter cloacae (n = 13)BUH: 13Male: 5Female: 8Burn: 8, Hematology: 1,Internal medicine: 2, Neurosurgery: 1,Intensive care: 1Urine: 1, rectal swab: 1,Catheter: 1,Pus: 10Pulmonary valves agenesis: 1,Burns: 8,Cancer: 1,Anal fistula: 1, Urinary tract infection: 1,Spina bifida: 115.38% (n = 2)100%61.54%30.77%7.69%Death: 38.46%blaOXA−48: 10, blaNDM: 1,blaVIM: 1, bla VIM + blaOXA−48:1K. aerogenes (n = 5)BUHMale : 2,Female : 3Intensive care: 3,Burn: 2Pus: 3,Blood: 2Burns: 3, Septicaemia: 1, Meningitis: 10%100%60%20%0%Death: 60% bla OXA−48 Raoultella terrigena (n = 9)BUHFemale: 2, Male: 7Burn: 4,Internal medicine: 2, Intensive care: 3Pus: 6,Catheter: 1,Liquid of ascites: 1, Urine: 1Burns: 6, Cirrhosis: 2, Urinary tract infection:1,33.33% (n = 3)100%33.33%22.22%11.11%Death: 66.67%blaOXA−48: 8,blaOXA−48+ blaVIM: 1Citrobacter koseri (n = 1)BUHMaleHematologyRectal swabCancer100%100%100%100%0%Death : 100% bla OXA−48 Enterobacter sakazakii (n = 3)BUHMale: 2Female : 1Hematology: 1,Burn: 1, Intensive care: 1Blood: 1, Pus: 2Pulmonary valves agenesis: 1,Burns: 1,Cancer: 10%100%100%0%0%Death: 66.67% bla OXA−48 Klebsiella oxytoca (n = 1)BUHFemaleNeurosurgeryCerebrospinal fluidSpina bifida100%100%100%100%0%Death : 0% bla OXA−48 Proteus mirabilis (n = 1)PHFemaleOtolaryngologyPusCancer0%100%0%0%100%Death : 0% bla OXA−48 Raoultella ornithinolytica (n = 1)BUHMaleNeurosurgeryTracheal aspirationsHead trauma0%100%0%0%0%Death: 100% bla OXA−48 Serratia ficaria (n = 1)BUHFemaleSurgeryUrineUrinary tract infection0%100%100%0%0%Death : 0%blaVIM + bla OXA−48 Serratia marcescens (n = 1)BUHMaleBurnPusBurns0%100%0%0%0%Death:100% bla OXA−48 BUH: Batna university hospital; PH: public hospital establishment; CAC: cancer centre Table 1Clinical and molecular characteristics of the obtained CPESpeciesHospitalGenderWardClinical specimensInfectionPrior hospitalisationETPIMPMEMCOLOutcomebla genesKlebsiella pneumoniae (n = 106)CAC: 11, PH:4, BUH: 91Female: 51Male: 55Burn: 50, Surgery: 5, Hematology: 11,Infectious disease: 4, Internal medicine: 1, Nephrology: 1, Neurosurgery: 4,Oncology: 1,pediatric Oncology: 1,Orthopaedics: 1,Intensive care: 26, Urology: 1Urine: 12, Rectal swab: 2,Blood:19, Catheter:5,Cerebrospinal fluid:1, Prosthesis equipment: 1, Skin sample: 1,Pus: 64, Urinary catheter: 1Stroke: 4,Pulmonary valves agenesis: 6,Burns: 55, Cancer: 12,Coma: 4,Acute respiratory distress: 3, Disembowelment: 1,Femoral neck fractures: 1, Hemothorax: 1, Urinary tract infection : 6,Leukaemia: 4, Abdominal mass: 1,Meningitis: 2, Pancreatitis: 1, Laparotomy wound: 1,Septicaemia: 1, Spina bifida: 2, Head trauma; 118.87% (n = 20)100%40.57%28.30%5.67%Death : 38.68%blaOXA−48: 94,blaNDM: 5,blaNDM +blaOXA−48: 3,blaVIM +blaOXA−48: 2, blaKPC +blaOXA−48 +blaVIM: 1,blaKPC +blaNDM +blaVIM: 1Escherichia coli (n = 37)BUH: 30,PH: 1, CAC: 6Male: 19Female: 18Burn: 6, Surgery: 2, Hematology: 16,Infectious disease: 1, Nephrology: 2,Neurosurgery: 4,Pediatric oncology: 1, Intensive care: 5Urine: 3, Rectal swab: 1,Blood: 15, Catheter: 1, LCR:3,pus: 13, Intubation probe: 1Stroke; 1,Burns: 7,Cancer: 8, Cholecystectomy: 1,Coma: 1,Respiratory distress:2,Urinary tract infection: 1,Chronic renal failure: 1,Leukaemia: 9, Meningitis: 2, Intestinal obstruction: 1, Septicaemia: 1, Spina bifida: 1, Head trauma: 162.16% (n = 23)100%45.95%27.03%0%Death: 35.14%blaOXA−48: 22, blaNDM: 4, blaVIM: 1 blaOXA−48 +blaNDM: 3 blaOXA−48 +blaVIM:3 blaNDM +blaVIM: 1 bla NDM + bla VIM + blaOXA−48: 2 bla KPC + bla VIM blaOXA−48: 1Enterobacter cloacae (n = 13)BUH: 13Male: 5Female: 8Burn: 8, Hematology: 1,Internal medicine: 2, Neurosurgery: 1,Intensive care: 1Urine: 1, rectal swab: 1,Catheter: 1,Pus: 10Pulmonary valves agenesis: 1,Burns: 8,Cancer: 1,Anal fistula: 1, Urinary tract infection: 1,Spina bifida: 115.38% (n = 2)100%61.54%30.77%7.69%Death: 38.46%blaOXA−48: 10, blaNDM: 1,blaVIM: 1, bla VIM + blaOXA−48:1K. aerogenes (n = 5)BUHMale : 2,Female : 3Intensive care: 3,Burn: 2Pus: 3,Blood: 2Burns: 3, Septicaemia: 1, Meningitis: 10%100%60%20%0%Death: 60% bla OXA−48 Raoultella terrigena (n = 9)BUHFemale: 2, Male: 7Burn: 4,Internal medicine: 2, Intensive care: 3Pus: 6,Catheter: 1,Liquid of ascites: 1, Urine: 1Burns: 6, Cirrhosis: 2, Urinary tract infection:1,33.33% (n = 3)100%33.33%22.22%11.11%Death: 66.67%blaOXA−48: 8,blaOXA−48+ blaVIM: 1Citrobacter koseri (n = 1)BUHMaleHematologyRectal swabCancer100%100%100%100%0%Death : 100% bla OXA−48 Enterobacter sakazakii (n = 3)BUHMale: 2Female : 1Hematology: 1,Burn: 1, Intensive care: 1Blood: 1, Pus: 2Pulmonary valves agenesis: 1,Burns: 1,Cancer: 10%100%100%0%0%Death: 66.67% bla OXA−48 Klebsiella oxytoca (n = 1)BUHFemaleNeurosurgeryCerebrospinal fluidSpina bifida100%100%100%100%0%Death : 0% bla OXA−48 Proteus mirabilis (n = 1)PHFemaleOtolaryngologyPusCancer0%100%0%0%100%Death : 0% bla OXA−48 Raoultella ornithinolytica (n = 1)BUHMaleNeurosurgeryTracheal aspirationsHead trauma0%100%0%0%0%Death: 100% bla OXA−48 Serratia ficaria (n = 1)BUHFemaleSurgeryUrineUrinary tract infection0%100%100%0%0%Death : 0%blaVIM + bla OXA−48 Serratia marcescens (n = 1)BUHMaleBurnPusBurns0%100%0%0%0%Death:100% bla OXA−48 BUH: Batna university hospital; PH: public hospital establishment; CAC: cancer centre Clinical and molecular characteristics of the obtained CPE Female: 51 Male: 55 Burn: 50, Surgery: 5, Hematology: 11, Infectious disease: 4, Internal medicine: 1, Nephrology: 1, Neurosurgery: 4, Oncology: 1, pediatric Oncology: 1, Orthopaedics: 1, Intensive care: 26, Urology: 1 Urine: 12, Rectal swab: 2, Blood:19, Catheter:5, Cerebrospinal fluid:1, Prosthesis equipment: 1, Skin sample: 1, Pus: 64, Urinary catheter: 1 Stroke: 4, Pulmonary valves agenesis: 6, Burns: 55, Cancer: 12, Coma: 4, Acute respiratory distress: 3, Disembowelment: 1, Femoral neck fractures: 1, Hemothorax: 1, Urinary tract infection : 6, Leukaemia: 4, Abdominal mass: 1, Meningitis: 2, Pancreatitis: 1, Laparotomy wound: 1, Septicaemia: 1, Spina bifida: 2, Head trauma; 1 blaOXA−48: 94, blaNDM: 5, blaNDM + blaOXA−48: 3, blaVIM + blaOXA−48: 2, blaKPC + blaOXA−48 + blaVIM: 1, blaKPC + blaNDM + blaVIM: 1 BUH: 30, PH: 1, CAC: 6 Male: 19 Female: 18 Burn: 6, Surgery: 2, Hematology: 16, Infectious disease: 1, Nephrology: 2, Neurosurgery: 4, Pediatric oncology: 1, Intensive care: 5 Urine: 3, Rectal swab: 1, Blood: 15, Catheter: 1, LCR:3, pus: 13, Intubation probe: 1 Stroke; 1, Burns: 7, Cancer: 8, Cholecystectomy: 1, Coma: 1, Respiratory distress:2, Urinary tract infection: 1, Chronic renal failure: 1, Leukaemia: 9, Meningitis: 2, Intestinal obstruction: 1, Septicaemia: 1, Spina bifida: 1, Head trauma: 1 blaOXA−48: 22, blaNDM: 4, blaVIM: 1 blaOXA−48 +blaNDM: 3 blaOXA−48 +blaVIM: 3 blaNDM +blaVIM: 1 bla NDM + bla VIM + blaOXA−48: 2 bla KPC + bla VIM blaOXA−48: 1 Male: 5 Female: 8 Burn: 8, Hematology: 1, Internal medicine: 2, Neurosurgery: 1, Intensive care: 1 Urine: 1, rectal swab: 1, Catheter: 1, Pus: 10 Pulmonary valves agenesis: 1, Burns: 8, Cancer: 1, Anal fistula: 1, Urinary tract infection: 1, Spina bifida: 1 blaOXA−48: 10, blaNDM: 1, blaVIM: 1, bla VIM + blaOXA−48: 1 Male : 2, Female : 3 Intensive care: 3, Burn: 2 Pus: 3, Blood: 2 Burn: 4, Internal medicine: 2, Intensive care: 3 Pus: 6, Catheter: 1, Liquid of ascites: 1, Urine: 1 blaOXA−48: 8, blaOXA−48+ blaVIM: 1 Male: 2 Female : 1 Hematology: 1, Burn: 1, Intensive care: 1 Pulmonary valves agenesis: 1, Burns: 1, Cancer: 1 blaVIM + bla OXA−48 Death: 100% BUH: Batna university hospital; PH: public hospital establishment; CAC: cancer centre Table 2Clinical and molecular characteristics of the obtained CPE-COLRIsolatesSpecies identificationAgeGenderWardIsolation siteInfectionPrior hospitalisationColistin MICCarbapenemase genesTreatmentOutcome 171 Raoultella terrigena 50 yearsMaleIntensive carePusBurnsNo˃256 mg/lblaOXA−48−like + blaVIMImipenem, amikacin, metronidazolDeath 38 Klebsiella pneumoniae 31 yearsMaleIntensive careUrinePulmonary valves agenesisNo4 mg/l bla OXA−48−like Imipenem, gentamicin, metronidazolAlive 152 Enterobacter cloacae 31 yearsFemaleInternal medicineUrineUrinary tract infectionNo˃256 mg/l bla OXA−48−like Cefotaxime, amikacin,metronidazolAlive 60 Klebsiella pneumoniae 30 yearsMaleBurnPusBurnsNo4 mg/l bla OXA−48−like Ceftazidime, amikacin, metronidazolDeath 41 Klebsiella pneumoniae 16 yearsMaleIntensive carePusLaparotomy woundNo8 mg/l bla OXA−48−like Imipenem, gentamicin, metronidazolAlive 21 Klebsiella pneumoniae 19 yearsMaleIntensive careUrineBurnsYes˃256 mg/l bla OXA−48−like Imipénène, amikacin, metronidazolDeath 69 Klebsiella pneumoniae 29 yearsMaleBurnPusBurnsNo64 mg/l bla OXA−48−like colistin, imipenem, vancomycinDeath 61 Klebsiella pneumoniae 48 yearsFemaleSurgeryProsthesis equipmentDisembowelmentYes64 mg/l bla OXA−48−like Cefazoline,Gentamicin,metronidazolAlive Table 2Clinical and molecular characteristics of the obtained CPE-COLRIsolatesSpecies identificationAgeGenderWardIsolation siteInfectionPrior hospitalisationColistin MICCarbapenemase genesTreatmentOutcome 171 Raoultella terrigena 50 yearsMaleIntensive carePusBurnsNo˃256 mg/lblaOXA−48−like + blaVIMImipenem, amikacin, metronidazolDeath 38 Klebsiella pneumoniae 31 yearsMaleIntensive careUrinePulmonary valves agenesisNo4 mg/l bla OXA−48−like Imipenem, gentamicin, metronidazolAlive 152 Enterobacter cloacae 31 yearsFemaleInternal medicineUrineUrinary tract infectionNo˃256 mg/l bla OXA−48−like Cefotaxime, amikacin,metronidazolAlive 60 Klebsiella pneumoniae 30 yearsMaleBurnPusBurnsNo4 mg/l bla OXA−48−like Ceftazidime, amikacin, metronidazolDeath 41 Klebsiella pneumoniae 16 yearsMaleIntensive carePusLaparotomy woundNo8 mg/l bla OXA−48−like Imipenem, gentamicin, metronidazolAlive 21 Klebsiella pneumoniae 19 yearsMaleIntensive careUrineBurnsYes˃256 mg/l bla OXA−48−like Imipénène, amikacin, metronidazolDeath 69 Klebsiella pneumoniae 29 yearsMaleBurnPusBurnsNo64 mg/l bla OXA−48−like colistin, imipenem, vancomycinDeath 61 Klebsiella pneumoniae 48 yearsFemaleSurgeryProsthesis equipmentDisembowelmentYes64 mg/l bla OXA−48−like Cefazoline,Gentamicin,metronidazolAlive Clinical and molecular characteristics of the obtained CPE-COLR Cefotaxime, amikacin, metronidazol Cefazoline, Gentamicin, metronidazol Antimicrobial susceptibility testing Antimicrobial susceptibility testing results showed that the obtained isolates were multidrug-resistant due to a high resistance rate to several antibiotics, including ampicillin (n = 179; 100%), ticarcillin (n = 179; 100%), piperacillin (n = 179; 100%), piperacillin-tazobactam (n = 179; 100%), cefalotin (n = 179; 100%), cefoxitin (n = 179; 100%), cefotaxime (n = 179; 100%), ceftazidime (n = 179; 100%), ceftriaxone (n = 179; 100%), amoxicillin-clavulanic acid (n = 178; 99.44%), temocillin (n = 164; 91.62%), cefepime (n = 155; 86.59%), and aztreonam (n = 156; 87.15%). Resistance rates to carbapenem agents among the CPE isolates were as follows: ertapenem (n = 179; 100%), imipenem (n = 80; 44.69%), and meropenem (n = 48; 26.82%). Most of the isolates were also highly resistant to trimethoprim-sulfamethoxazole (n = 164; 91.62%), nalidixic acid (n = 162; 90.50%), tobramycin (n = 156; 87.15%), gentamicin (n = 133; 74.30%), ofloxacin (n = 124; 69.27%), ciprofloxacin (n = 115; 64.25%), and amikacin (n = 78; 43.58%). The colistin selective isolation step and broth microdilution results revealed that eight isolates were resistant to colistin (n = 8; 4.47%) (six K. pneumoniae, one E. cloacae and one R. terrigena) and all of them were recovered from patients hospitalised in Batna university hospital. The six K. pneumoniae had high colistin MICs ranging from 4 mg/mL to > 256 mg/mL, while the E. cloacae and R. terrigena isolates had a colistin MIC of 256. All the obtained E. coli isolates were sensitive to colistin. The antibiogram results of the obtained Enterobacterales isolates are presented in Table 3. Table 3Antibiotic resistance percentage of the obtained CPE speciesAntibioticK. pneumoniae (R%)E. coli (R%)E. cloacae (R%)Other Enterobacterale (R%)Ampicillin100%100%100%100%Ticarcillin100%100%100%100%Temocillin93.40%83.78%84.62%100%Amoxicillin-clavulanic acid99.06%100%100%100%Piperacillin100%100%100%100%Piperacillin-tazobactam100%100%100%100%Cefalotin100%100%100%100%Cefoxitin100%100%100%100%Cefotaxime100%100%100%100%Ceftazidime100%100%100%100%Ceftriaxone100%100%100%100%Cefepime85.85%83.78%92.31%86.96%Aztreonam93.40%70.27%61.54%78.26%Ertapenem100%100%100%100%Imipenem40.57%45.95%61.54%52/17%Meropenem28.30%27.03%30.77%21.74%Amikacin53.78%27.03%46.15%21,74Tobramycin90.57%67.57%92.31%95.65%Gentamicin76.42%59.46%84.62%78.26%Nalidixic acid87.74%97.30%92.31%91.30%Ciprofloxacin72.64%54.05%61.54%43.48%Ofloxacin78.30%59.46%61.54%47.83%Trimethoprim-sulfamethoxazole93.40%81.08%84.62%91.30%Colistin5.66%0%7.69%4.35% Table 3Antibiotic resistance percentage of the obtained CPE speciesAntibioticK. pneumoniae (R%)E. coli (R%)E. cloacae (R%)Other Enterobacterale (R%)Ampicillin100%100%100%100%Ticarcillin100%100%100%100%Temocillin93.40%83.78%84.62%100%Amoxicillin-clavulanic acid99.06%100%100%100%Piperacillin100%100%100%100%Piperacillin-tazobactam100%100%100%100%Cefalotin100%100%100%100%Cefoxitin100%100%100%100%Cefotaxime100%100%100%100%Ceftazidime100%100%100%100%Ceftriaxone100%100%100%100%Cefepime85.85%83.78%92.31%86.96%Aztreonam93.40%70.27%61.54%78.26%Ertapenem100%100%100%100%Imipenem40.57%45.95%61.54%52/17%Meropenem28.30%27.03%30.77%21.74%Amikacin53.78%27.03%46.15%21,74Tobramycin90.57%67.57%92.31%95.65%Gentamicin76.42%59.46%84.62%78.26%Nalidixic acid87.74%97.30%92.31%91.30%Ciprofloxacin72.64%54.05%61.54%43.48%Ofloxacin78.30%59.46%61.54%47.83%Trimethoprim-sulfamethoxazole93.40%81.08%84.62%91.30%Colistin5.66%0%7.69%4.35% Antibiotic resistance percentage of the obtained CPE species Genetic characterisation of the bla and mcr genes among CPE isolates Of the tested CPE isolates, 179 isolates harboured at least one carbapenemase gene in which blaOXA−48−like gene alone was the most detected one and carried by 147 isolates from all the identified Enterobacterales species (82.12%). Other carbapenemase-related bla genes which were detected included, blaNDM (n = 10; 5.59%) (five K. pneumoniae, four E. coli, and one E. cloacae), blaVIM (n = 2), the combination blaVIM and blaOXA−48−like (n = 8; 4.47%), as well as the association of blaKPC, blaVIM and blaOXA−48−like (n = 2; 1.12%). In addition, two E. coli isolates simultaneously harboured the blaNDM, blaVIM and blaOXA−48−like genes (n = 2; 1.12%), however, blaVIM and blaNDM were found in only one E. coli isolate (n = 1; 0.56%). A single K. pneumoniae isolate carried the association of blaKPC, blaNDM and blaVIM (n = 1; 0.56%), while six isolates were found to simultaneously carry the blaNDM and blaOXA−48−like genes (n = 6; 3.35%). The mcr-1 gene was not detected among these isolates. The Fisher’s exact test revealed a statistically significant association between the presence of the blaOXA−48 gene and the hospital establishment (p = 0.042). However, it is not statistically associated with the hospitalisation unit (p-value = 0.275). For the remaining examined genes in this study, no statistically significant associations were found between the occurrence of carbapenemase gene and either the establishment, the ward or the bacterial species. The statistical analysis results revealed also a statistically significant association between the presence of the blaOXA−48 or the blaVIM genes and the bacterial species with a P-value of 0.001 (p < 0.001, strong correlation between the two variables) and 0.046 (p < 0.046, this correlation is relatively weak due to the p-value being close to the threshold of significance) respectively. The genetic characterisation of CPE and CPE-COLR isolates are presented in Tables 1 and 2 respectively. The distribution of Enterobacterales species across hospital establishment-wards and the percentage of carbapenemase-encoding genes is presented in Figs. 2 and 3. Fig. 2Bar plots illustrating the distribution of CPE species across hospital establishment-wards, percentage of carbapenemase genes Bar plots illustrating the distribution of CPE species across hospital establishment-wards, percentage of carbapenemase genes Fig. 3Bar plots illustrating percentages of carbapenemase-encoding genes across hospital establishment-wards Bar plots illustrating percentages of carbapenemase-encoding genes across hospital establishment-wards Discussion CREs are currently considered to be a major public health risk around the world, since they are one of the principal causes of death among patients with hospital-acquired infections. This study assessed the antibiotic resistance patterns and the prevalence of carbapenemase-encoding-genes among Enterobacterales species isolated from clinical specimens of patients in three hospitals in the city of Batna in Algeria. Our study demonstrates a high prevalence and diversity of isolates harbouring carbapenemase-encoding genes among the obtained CREs where, out of 201 CRE isolates, 179 were positive for carbapenemase production (89.05%). This is much higher than previous estimates in the city of Annaba, Algeria, where only 19.12% of the obtained CRE isolates were positive for carbapenemase production [13]. The detection of such rate and diversity of the carbapenemase genes are likely the result of several factors, including prolonged hospitalisation, infection control practices, medical device use, and the use of antibiotics especially carbapenems in hospital, healthcare and community settings [19–21]. Other factors, such as low compliance with infection control measures and inadequate hospital structure have probably been related to or facilitated the emergence and spread of isolates with such levels of resistance [22]. In the present study, isolates with carbapenemase activity were mostly obtained from patients in Batna university hospital (n = 156), followed by cancer centre (n = 17), and the public hospital establishment (n = 6). Several reasons could explain the high prevalence of such levels of resistance in Batna university hospital including unregulated and inappropriate use of antibiotics, environmental non-conformities and healthcare professionals working in diverse sectors, either simultaneously or consecutively [23]. In our study, K. pneumoniae was found to be the predominant species among bacterial isolates, followed by E. coli and E. cloacae. This finding was consistent with studies conducted worldwide which have reported that K. pneumoniae, E. coli and E. cloacae were the most carriers of carbapenemase genes [12, 13, 24, 25]. CPEs have been reported in all continents, however, the molecular epidemiology of the resistance mechanisms depends on the geographic region [5, 7]. In the present study, 147 (82.12%) of the obtained carbapenemase-positive Enterobacterales isolates were confirmed to carry the blaOXA−48−like gene. The predominance of the blaOXA−48−like gene in the three hospitals is unsurprising, as previous studies have reported that Algeria is an endemic country for OXA-48 type carbapenemases [5, 7, 12, 13, 24]. These results align with a previous study conducted in Algeria, showing that 100% of the obtained Enterobacterales isolates carried the blaOXA−48 gene [13]. Our results also support the findings of the study of Abderrahim et al. carried out between April 2016 and December 2018 on patients in the Annaba university hospital, where the NDM-type was present in only 11.34% (3/29) of isolates and blaOXA−48−like genes were the most prevalent carbapenemase-encoding genes, present in 89.6% (26/29) of isolates [24]. In addition, this result was also similar to that reported in South Africa where the commonest carbapenemase genes were blaOXA−48 (52%) flowed by blaNDM (34%). However different findings were reported in Egypt in which blaNDM was the most common gene followed by blaVIM (30%), blaIMP (26.7%), and blaKPC (23.3%) [26, 27]. Other carbapenemase-encoding-genes also were detected in the present study, including the blaKPC, blaVIM, and blaNDM genes. The blaVIM and blaKPC genes were found in smaller numbers in this study (8.94%; n = 16), even though these genes have been reported to spread rapidly worldwide [6]. The blaVIM gene is mostly found in Europe and Latin America although the main endemic focus is located in Greece, Spain and Italy [28–30]. In Algeria, the blaVIM genes have so far been associated with non-fermenting Gram negative bacteria isolates [16, 31]. The blaKPC carbapenemase gene detected in this study was limited to only three patients and associated with other carbapenemase genes, including the association of blaKPC, blaVIM and blaOXA−48−like (n = 2) and the combination of blaKPC, blaNDM and blaVIM (n = 1). This is in contrast to other regions such as Greece, Italy, the USA, and some countries in Latin America, where the blaKPC gene continues to be the predominant carbapenemase gene [32–34]. As mentioned above, the blaOXA−48-like and blaNDM genes were frequently detected in clinical Enterobacterales isolates in Algeria [12, 13, 24], while the prevalence of the blaKPC gene remained low. This result supports those of two studies which have reported that the blaKPC is the lowest detected gene in our country, where it was detected among Enterobacterales isolates from hospitalised patients in two Algerian cities: Sétif (n = 3, 21.42%) and Annaba (n = 1) in Algeria [35, 36]. In the present study, the obtained CPE strains are mostly isolated from hospitalised burns patients (n = 72), these strains were positive for at least one cabapenemase gene including blaOXA−48−like gene (n = 64), blaNDM (n = 2), the association blaNDM and blaOXA−48−like (n = 2), blaVIM and blaOXA−48−like (n = 2), blaVIM (n = 1) and the association blaVIM, blaKPC and blaOXA−48−like (n = 1). Seventy burn isolates were obtained from pus samples and mostly identified as K. pneumoniae (n = 50). Indeed, the loss of the skin barrier, invasive devices, immunosuppression related to the burn, the use of broad-spectrum antibiotics as a last resort in burn victims, the longer hospitalisation and the presence of polymicrobial infections are factors that contribute to the occurrence of this type of infection. These results in contrast to those of previous studies conducted in Algeria, showed that the burn ward could be considered as an important source of CPE isolates from hospitalised patients [12, 13, 37]. In our study, seventeen CPE isolates (all of them carrying the blaOXA−48−like gene) were isolated from hospitalised cancer patients at Cancer Centre, Batna, Algeria. Cancer patients are frequently receiving prolonged and aggressive antibiotic therapy due to neutropaenia, especially among leukaemic patients where enterobacterial infections require the administration of antimicrobial therapy for up to 15 days, this, therefore, increases the rates of antibiotic resistance. This high prevalence of OXA-48-like among cancer patients is alarming for several reasons including the high rate of diffusion via transferable plasmids, difficulty in detection using reliable phenotypic methods, and treatment failure [38]. Resistance to both colistin and carbapenem antibiotics was observed in eight carbapenemase-positive isolates (4.47%) (six K. pneumoniae, one E. cloacae and one R. terrigena) in this study, three of them were resistant to both imipenem and colistin. The eight cases of ColR-CPR isolates were detected only in the Batna university hospital and none were isolated from the other hospitals. Most of the obtained isolates were from the intensive care unit (n = 4) and were mostly (n = 6) obtained from patients with no prior record of hospitalisation. In our hospitals, the combination of imipenem, amikacin, and metronidazole, as well as ceftazidime, amikacin, and metronidazole, and the combination of imipenem and colistin were used to treat patients infected by these isolates, and had led to a treatment failure. In Algeria, the blaOXA−48 gene has been reported among colistin-resistant K. pneumoniae isolates with mutations in the PmrA/B and mgrB gene [14]. In Algeria this gene has been reported from different niches including vegetables, animals and humans [16, 39, 40]. Conclusions In conclusion, this study highlighted the emergence of carbapenemase production as a predominant resistance mechanism among CREs in Batna, Algeria. In addition, we noted that carbapenemase-producing Enterobacterales isolates from hospitalised patients in Algeria, carried mostly blaOXA−48-like genes, followed by the blaNDM and blaVIM genes, respectively. In the present study different carbapenemase genes combination were detected including: blaVIM and blaOXA−48−like; blaKPC, blaVIM and blaOXA−48−like; blaVIM and blaNDM; blaKPC, blaNDM and blaVIM; blaNDM and blaOXA−48−like genes. To the best of our knowledge, this is the first study to report the aforementioned carbapenemase combinations in Algeria. Our study, therefore, underscores the need for active surveillance of CREs in our hospitals.